Art. 17 Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…

Making available on the market and use of biocidal products

In forcecited 28×
1.

Biocidal products shall not be made available on the market or used unless authorised in accordance with this Regulation.

2.

Applications for authorisation shall be made by, or on behalf of, the prospective authorisation holder.

Applications for national authorisation in a Member State shall be submitted to the competent authority of that Member State (‘the receiving competent authority’).

Applications for Union authorisation shall be submitted to the Agency.

3.

An authorisation may be granted for a single biocidal product or a biocidal product family.

4.

An authorisation shall be granted for a maximum period of 10 years.

5.

Biocidal products shall be used in compliance with the terms and conditions of the authorisation stipulated in accordance with Article 22(1) and the labelling and packaging requirements laid down in Article 69.

Proper use shall involve the rational application of a combination of physical, biological, chemical or other measures as appropriate, whereby the use of biocidal products is limited to the minimum necessary and appropriate precautionary steps are taken.

Member States shall take necessary measures to provide the public with appropriate information about the benefits and risks associated with biocidal products and ways of minimising their use.

6.

The authorisation holder shall notify each competent authority that has granted a national authorisation for a biocidal product family of each product within the biocidal product family at least 30 days before placing it on the market, except where a particular product is explicitly identified in the authorisation or the variation in composition concerns only pigments, perfumes and dyes within the permitted variations. The notification shall indicate the exact composition, trade name and suffix to the authorisation number. In the case of a Union authorisation, the authorisation holder shall notify the Agency and the Commission.

7.

The Commission shall, by means of an implementing act, specify procedures for the authorisation of the same biocidal products by the same or different enterprises under the same terms and conditions. That implementing act shall be adopted in accordance with the examination procedure referred to in Article 82(3).

The 10 that are cited most themselves, of 28.

  • Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure…Law

    … 1.], и по-специално член 17, параграф 7 от него, като има предвид, че:

  • Gesetz zum Schutz vor gefährlichen Stoffen12e12f28Law

    … § 8 ist entsprechend anzuwenden. (2) Die Bundesstelle für Chemikalien unterrichtet gemäß Artikel 17 Absatz 5 Unterabsatz 3 der Verordnung (EU) Nr. 528/2012 die Öffentlichkeit über 1. Nutzen und Risiken des Einsatzes von …

  • The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Am…2Law

    … as it had effect immediately before IP completion day; “receiving competent authority” has the meaning given in Article 17 of Regulation (EU) No 528/2012 as it had effect immediately before IP completion day; “reference Member …

  • The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Am…Law

    … as it had effect immediately before IP completion day; “receiving competent authority” has the meaning given in Article 17 of Regulation (EU) No 528/2012 as it had effect immediately before IP completion day; “reference Member …

  • Opinion of Advocate General Kokott delivered on 17 October 2019. Darie BV v Staatssecretaris van Infrastructuur en Milieu.Decision

    Pursuant to Article 17(1) of the Biocides Regulation, biocidal products require authorisation: ‘Biocidal products shall not be made available on the market or used unless authorised in accordance with this Regulation.’

    17 Oct 2019 · 62018CC0592

  • Code de l'environnementr522-10Law

    … sur le marché d'un produit biocide appartenant à une famille de produits en application du paragraphe 6 de l'article 17 du règlement (UE) n° 528/2012 du 22 mai 2012 et que cette notification satisfait aux critères définis à ce même …

  • Judgment of the Court (Third Chamber) of 19 January 2023. Comité interprofessionnel des huiles essentielles françaises (CIHEF) and Others v Decision

    It follows that the rules of the said regulation relating to the making available on the market and use of biocidal products are sufficiently broad to cover commercial practices linked to the sale of those products. However, it is worth …

    19 Jan 2023 · 62021CJ0147

  • Judgment of the Court (Ninth Chamber) of 19 December 2019. Darie BV v Staatssecretaris van Infrastructuur en Milieu.Decision

    By decision of 13 January 2017, the Secretary of State, on the basis of the combined provisions of Articles 43 and 86 of the Wgb and of Article 17(1) of Regulation No 528/2012, ordered Darie, subject to a penalty payment of EUR 1000 per …

    19 Dec 2019 · 62018CJ0592

  • Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…95nLaw

    … as it had effect immediately before IP completion day; “receiving competent authority” has the meaning given in Article 17 of Regulation (EU) No 528/2012 as it had effect immediately before IP completion day; “reference Member …

  • Opinion of Advocate General Emiliou delivered on 2 June 2022. Comité interprofessionnel des huiles essentielles françaises (CIHEF) and OtherDecision

    As the Commission observes, the BPR is mainly concerned with the authorisation of biocidal products for making them available on the market and with their use. The provisions related to the use of biocidal products are rather limited and …

    2 Jun 2022 · 62021CC0147